NAGE
Niagen Bioscience, Inc. · Healthcare · Biotechnology
Last
$5.06
−$0.13 (−2.41%) 4:00 PM ET
Prev close $5.18
Open $5.19
Day high $5.19
Day low $4.95
Volume 1,749,334
Avg vol 832,537
Mkt cap
$403.02M
P/E ratio
21.06
FY Revenue
$124.71M
EPS
0.24
Gross Margin
63.89%
Sector
Healthcare
AI report sections
NAGE
Niagen Bioscience, Inc.
No AI report section text found yet for this symbol.
Volume vs average
Intraday (cumulative)
+132% (Above avg)
Vol/Avg: 2.32×
RSI
41.21 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
+0.01 (Strong)
MACD: 0.02 Signal: 0.01
Short-Term
+0.04 (Strong)
MACD: -0.26 Signal: -0.30
Long-Term
+0.00 (Strong)
MACD: -0.45 Signal: -0.45
Intraday trend score 60.00

Latest news

NAGE 1 article Positive: 0 Neutral: 1 Negative: 0
Neutral GlobeNewswire Inc. • Bbb National Programs
National Advertising Division Finds Certain Reus Cata-Kor NAD+ Claims Supported; Recommends Others Be Modified or Discontinued

The National Advertising Division reviewed claims by Reus Research for its Cata-Kor NAD+ products, finding some claims supported while recommending modifications or discontinuation of others due to insufficient substantiation of health benefits and inadequate influencer disclosures.

NAGE NAD+ dietary supplements advertising claims product testing influencer marketing
Sentiment note

Initiated the challenge against Reus Research, but no specific negative outcomes were detailed for the company

News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal